Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 8/20 | 0.46 |
| ▸ | HTR1A | P08908 | 2/20 | 0.38 |
| ▸ | HTR7 | P34969 | 2/20 | 0.38 |
| ▸ | HTR6 | P50406 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 2/20 | 0.33 |
| ▸ | BTK | Q06187 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20754056 | 0.89 | AHR (0.46) | AHREGFRMCL1JAK2BTK | |
| SCHEMBL24118930 | 0.85 | CSF1R (0.40) | CSF1RJAK2BTKMEN1CYP2C19 | |
| SCHEMBL27026408 | 0.84 | LPL (0.38) | CSF1RJAK2BTKMEN1CYP2C19 | |
| SCHEMBL5019780 | 0.83 | MEN1 (0.46) | AHRJAK2BTKMEN1CYP2C19 | |
| SCHEMBL21178341 | 0.82 | AHR (0.47) | AHRHTR1AHTR7HTR6EGFR | |
| SCHEMBL21204178 | 0.82 | MEN1 (0.41) | AHRCSF1RMEN1CYP2C19KMT2A | |
| SCHEMBL21339756 | 0.82 | MEN1 (0.43) | AHRCSF1RJAK2BTKMEN1 | |
| SCHEMBL26863064 | 0.82 | MEN1 (0.43) | AHRCSF1RJAK2BTKMEN1 | |
| SCHEMBL22135393 | 0.82 | ALOX5 (0.39) | AHRCSF1RMEN1CYP2C19KMT2A | |
| SCHEMBL22708833 | 0.82 | LIPG (0.47) | CSF1RMEN1CYP2C19KMT2ADYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260143902-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-21 | — | — | US | disclosed |
| US-20250063936-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-02-20 | — | — | US | disclosed |
| US-20240209013-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240209013-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-06-27 | — | — | US | disclosed |
| EP-4270510-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-11-01 | — | — | EP | disclosed |
| US-20230331757-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230331757-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230331757-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| WO-2023022480-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | 엘티소재주식회사 | 2023-02-23 | — | — | WO | disclosed |
| US-20220328769-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2022-10-13 | — | — | US | disclosed |
| WO-2021029634-A1 | NOVEL COMPOUND, AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | 주식회사 엘지화학 | 2021-02-18 | — | — | WO | disclosed |
| WO-2019143109-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 주식회사 두산 | 2019-07-25 | — | — | WO | disclosed |
| US-20190058131-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2019-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260143902-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRB, LIFR | AHR 374/4885HTR1A 2499/4885HTR7 2688/4885 |
| US-20220328769-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | AHR 21/4885HTR1A 449/4885HTR7 1958/4885 |
| US-20240209013-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, SSB, L1CAM | AHR 1218/4885HTR1A 3228/4885HTR7 3714/4885 |
| US-20230331757-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, SSB, L1CAM | AHR 1218/4885HTR1A 3228/4885HTR7 3714/4885 |
| US-20250063936-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OPRM1 | AHR 3383/4885HTR1A 1911/4885HTR7 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.